title: Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans.
abstract: Cell cloning by limiting dilution in 96-well microtiter plates has been employed to isolate colonies of human T-lymphocytes resistant to the purine analogue, 6-thioguanine (TG). These colonies show stability of the TG-resistant (TG1) phenotype, lack hypoxanthine guanine phosphoribosyl transferase (HPRT) activity and thus appear to be the result of in vivo somatic cell mutation events. In order to employ this T-lymphocyte cloning assay for quantitative determination of the in vivo TGr mutant frequency in humans, we have defined the optimal conditions for T-cell colony formation with both nonselected and TG-selected cells. The parameters investigated include medium, serum, amount of the mitogen phytohaemagglutinin, amount of T-cell growth factor (TCGF) and the number of irradiated feeder or accessory cells. Under the optimal conditions, the fraction of positive wells is proportional to the number of cells plated per well with both nonselection and TG selection conditions. T-cell cloning efficiencies therefore are independent of inoculum size. There was some evidence for a decline in TGr mutant cell cloning at densities greater than 2 x 10(4) cells per round-bottom well, possibly due to metabolic cooperation between wild-type and mutant cells. The conditions defined in this study appear to provide a quantitative measurement of the in vivo TGr mutant frequency in human T-lymphocytes.
authors.affiliation: University of Vermont, Genetics Laboratory, Burlington 05401.
authors.forename: J P
authors.initials: JP
authors.lastname: O'Neill
authors.forename: M J
authors.initials: MJ
authors.lastname: McGinniss
authors.forename: J K
authors.initials: JK
authors.lastname: Berman
authors.forename: L M
authors.initials: LM
authors.lastname: Sullivan
authors.forename: J A
authors.initials: JA
authors.lastname: Nicklas
authors.forename: R J
authors.initials: RJ
authors.lastname: Albertini
mesh_terms: D000938:Antigen-Presenting Cells / Q000502:physiology / Q000528:radiation effects; D001769:Blood; D003114:Colony-Forming Units Assay; D003470:Culture Media; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D008213:Lymphocyte Activation; D009154:Mutation; D010835:Phytohemagglutinins / Q000494:pharmacology; D013601:T-Lymphocytes / Q000166:cytology*; D013866:Thioguanine / Q000494:pharmacology*
chemical_list: D003470:Culture Media; D007376:Interleukin-2; D010835:Phytohemagglutinins; D013866:Thioguanine